Motoyama Daisuke, Matsushita Yuto, Watanabe Hiromitsu, Tamura Keita, Otsuka Atsushi, Fujisawa Masato, Miyake Hideaki
Department of Urology Hamamatsu University School of Medicine Hamamatsu Japan.
Department of Developed Studies for Advanced Robotic Surgery Hamamatsu University School of Medicine Hamamatsu Japan.
IJU Case Rep. 2023 Nov 21;7(2):96-99. doi: 10.1002/iju5.12673. eCollection 2024 Mar.
A newly developed surgical robot system, hinotori, with various unique advantages has been in clinical use in Japan; however, there have not been any studies of robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using hinotori.
We describe two male patients aged 67 and 76 years old with right renal cell carcinoma and a level II and I inferior vena cava tumor thrombus, respectively, undergoing robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using hinotori. Both operations were successfully completed with a purely robotic procedure without any major perioperative complications, resulting in the following findings: time using robotic system, 158 and 156 min; total operative time, 228 and 214 min; estimated blood loss, 535 and 200 mL, respectively.
Based on our first experience, robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using hinotori may be an effective treatment for renal cell carcinoma with inferior vena cava tumor thrombus ≤level II.
一种新开发的具有多种独特优势的手术机器人系统“日之鸟”已在日本投入临床使用；然而，尚未有关于使用“日之鸟”进行机器人辅助根治性肾切除术和下腔静脉肿瘤血栓切除术的研究。
我们描述了两名分别为67岁和76岁的男性患者，他们分别患有右肾细胞癌以及II级和I级下腔静脉肿瘤血栓，均接受了使用“日之鸟”进行的机器人辅助根治性肾切除术和下腔静脉肿瘤血栓切除术。两台手术均通过纯机器人手术成功完成，且未出现任何重大围手术期并发症，结果如下：使用机器人系统的时间分别为158分钟和156分钟；总手术时间分别为228分钟和214分钟；估计失血量分别为535毫升和200毫升。
基于我们的首次经验，使用“日之鸟”进行机器人辅助根治性肾切除术和下腔静脉肿瘤血栓切除术可能是治疗下腔静脉肿瘤血栓≤II级的肾细胞癌的有效方法。
